Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis
Authors
Keywords
Hepatocellular carcinoma, Meta-analysis, Enzyme-linked immunoassays, Biomarkers, Cancer detection and diagnosis, Publication ethics, China, Immunoblotting
Journal
PLoS One
Volume 10, Issue 10, Pages e0140067
Publisher
Public Library of Science (PLoS)
Online
2015-10-07
DOI
10.1371/journal.pone.0140067
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysis on Postoperative Efficacy of Radical Hepatectomy for Patients with Non-HBV/HCV Hepatocellular Carcinoma
- (2015) Zhi-Ming Zhang et al. Asian Pacific Journal of Cancer Prevention
- A precise approach in large scale core-fucosylated glycoprotein identification with low- and high-normalized collision energy
- (2015) Cheng Ma et al. Journal of Proteomics
- Superparamagnetic iron oxide-enhanced magnetic resonance imaging for focal hepatic lesions: Systematic review and meta-analysis
- (2015) You-Wei Li WORLD JOURNAL OF GASTROENTEROLOGY
- Diagnosis Accuracy of Serum Glypican-3 in Patients with Hepatocellular Carcinoma: A Systematic Review with Meta-analysis
- (2014) Xiaobo Jia et al. ARCHIVES OF MEDICAL RESEARCH
- Emerging trends in hepatocellular carcinoma incidence and mortality
- (2014) Basile Njei et al. HEPATOLOGY
- Systematic Reviews of Diagnostic Test Accuracy
- (2013) Mariska M.G. Leeflang ANNALS OF INTERNAL MEDICINE
- A Combination of a-Fetoprotein and Des-γ-Carboxy Prothrombin Is Superior in Detection of Hepatocellular Carcinoma
- (2013) Judith M. Ertle et al. DIGESTION
- Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis
- (2013) Yichen Wang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis
- (2012) Caroline D. M. Witjes et al. Hepatology International
- A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma
- (2011) Kaori Morota et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations
- (2011) Manabu Morimoto et al. International Journal of Clinical Oncology
- Diagnostic and Prognostic Validity of Golgi Protein 73 in Hepatocellular Carcinoma
- (2010) Hasan Özkan et al. DIGESTION
- Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
- (2010) Yilei Mao et al. GUT
- Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases
- (2010) Liyuan Tian et al. INTERNATIONAL JOURNAL OF CANCER
- Significance of Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy
- (2009) Kentaroh Yamamoto et al. ANNALS OF SURGICAL ONCOLOGY
- Novel Fucosylated Biomarkers for the Early Detection of Hepatocellular Carcinoma
- (2009) M. Wang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The global burden of cancer: priorities for prevention
- (2009) M. J. Thun et al. CARCINOGENESIS
- GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population
- (2009) Jin-song Hu et al. MEDICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More